2
Participants
Start Date
October 31, 2011
Primary Completion Date
January 31, 2012
Study Completion Date
March 31, 2013
Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)
intratumoral or intravenous dosage: 10e9 pfu Intravenous: administered over 60 minutes Intratumoral: direct injection into a single liver lesion
Ottawa Hospital and Research Institute (OHRI), Ottawa
Lead Sponsor
Jennerex Biotherapeutics
INDUSTRY